Literature DB >> 22280308

Loss of control of HIV viremia associated with the fat malabsorption drug orlistat.

Stephen J Kent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280308     DOI: 10.1089/AID.2012.0017

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  5 in total

1.  The Relationship Between Caffeine Intake and Immunological and Virological Markers of HIV Disease Progression in Miami Adult Studies on HIV Cohort.

Authors:  Venkataraghavan Ramamoorthy; Adriana Campa; Muni Rubens; Sabrina S Martinez; Christina Fleetwood; Tiffanie Stewart; Juan P Liuzzi; Florence George; Hafiz Khan; Yinghui Li; Marianna K Baum
Journal:  Viral Immunol       Date:  2017-04-14       Impact factor: 2.257

Review 2.  Benefit-risk assessment of orlistat in the treatment of obesity.

Authors:  Priya Sumithran; Joseph Proietto
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

3.  The anti-obesity drug orlistat reveals anti-viral activity.

Authors:  Elisabeth Ammer; Sandor Nietzsche; Christian Rien; Alexander Kühnl; Theresa Mader; Regine Heller; Andreas Sauerbrei; Andreas Henke
Journal:  Med Microbiol Immunol       Date:  2015-02-14       Impact factor: 3.402

4.  EHFPI: a database and analysis resource of essential host factors for pathogenic infection.

Authors:  Yang Liu; Dafei Xie; Lu Han; Hui Bai; Fei Li; Shengqi Wang; Xiaochen Bo
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

5.  High sensitivity of Giardia duodenalis to tetrahydrolipstatin (orlistat) in vitro.

Authors:  Juliane Hahn; Frank Seeber; Herbert Kolodziej; Ralf Ignatius; Michael Laue; Toni Aebischer; Christian Klotz
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.